#Expert Research: Biodegradable ultrasound implant could improve brain tumour treatments

Jul 17, 2023

2 min

Thanh Nguyen, Ph.D.

One of the challenges in treating certain types of brain cancer is the way that the blood-brain barrier prevents chemotherapy drugs from reaching the tumors they're meant to target.


UConn's Thanh Nguyen, a biomedical and mechanical engineer, is developing new technology that could improve how we are able to treat brain tumors. 


He recently spoke with Physics World about this groundbreaking research:



A new type of biodegradable ultrasound implant based on piezoelectric nanofibres could improve outcomes for patients with brain cancer.

Researchers led by Thanh Nguyen from the the University of Connecticut’s department of mechanical engineering fabricated the devices from crystals of glycine, an amino acid found in the human body. Glycine is not only non-toxic and biodegradable, it is also highly piezoelectric, enabling the creation of a powerful ultrasound transducer that could help treat brain tumours.

Brain tumours are particularly difficult to treat because the chemotherapy drugs that would be effective in tackling them are blocked from entering the brain by the blood–brain barrier (BBB). This barrier is a very tight junction of cells lining the blood vessel walls that prevents particles and large molecules from making their way through and damaging the brain. However, ultrasound can be safely used to temporarily alter the shape of the barrier cells such that chemotherapy drugs circulating in the bloodstream can pass through to the brain tissues.

Currently, to achieve such BBB opening requires the use of multiple ultrasound transducers located outside the body, together with very high intensity ultrasound to enable penetration through the thick human skull bone.

“That strong ultrasound can easily damage brain tissues and is not practical for multiple-time applications which are required to repeatedly deliver chemotherapeutics,” Nguyen tells Physics World.

By contrast, the team’s new device would be implanted during the tumour removal surgery, and “can generate a powerful acoustic wave deep inside the brain tissues under a small supplied voltage to open the BBB”. The ultrasound would be triggered repeatedly as required to deliver the chemotherapy that kills off the residual cancer cells at tumour sites. After a set period of time following treatment the implant biodegrades, thereby eliminating the need for surgery to remove it.

The research, reported in Science Advances, demonstrated that the team’s device used in conjunction with the chemotherapy drug paclitaxel significantly extended the lifetime of mice with glioblastomas (the most aggressive form of brain tumour) compared with mice receiving the drugs but no ultrasound treatment.




This is fascinating research and if you are interesting in covering this topic, then let us help.


Professor Nguyen focuses on biointegrated materials and devices at nano- and micro-scales for applications in biomedicine, and he's available to speak to media about his research. Simply click on his icon now to arrange an interview today.



Connect with:
Thanh Nguyen, Ph.D.

Thanh Nguyen, Ph.D.

Professor

Professor Nguyen focuses on biointegrated materials and devices at nano- and micro-scales for applications in biomedicine

VaccinationsDrug DeliveryNano
Powered by

You might also like...

Check out some other posts from University of Connecticut

How Worried Should We Be About Hantavirus? featured image

2 min

How Worried Should We Be About Hantavirus?

An outbreak of an uncommon but not unheard-of illness is responsible for the deaths of at least three people who were on an international cruise ship. With the rest of the passengers and crew under observation in their home countries — including 18 Americans who went to a quarantine facility at the University of Nebraska — how worried do we need to be about hantavirus? Dr. David Banach, UConn Health infectious diseases physician and hospital epidemiologist, joins Dr. Anthony Alessi to explain what we’re dealing with, the public health implications, and how, unlike COVID, the medical community at least has some history with this virus. You can check out the podcast here: It doesn’t spread in the same way that COVID does, in the sense that there’s no established sort of asymptomatic or pre-symptomatic spread. — Dr. David Banach Dr. Banach explains that hantavirus is a rare but serious virus carried primarily by rodents and spread through exposure to rodent waste or contaminated environments. While most cases are isolated, clusters can occasionally occur. The discussion compares hantavirus to COVID-19, with Dr. Banach emphasizing that hantavirus spreads much less easily between humans and is therefore less likely to become a global pandemic. However, it can cause severe cardiopulmonary illness with a significantly higher mortality rate than COVID. There is currently no vaccine or specific antiviral treatment, meaning care is largely supportive for patients who become critically ill. Dr. Banach also addresses public anxiety and misinformation surrounding the outbreak, encouraging people to rely on trusted organizations such as the World Health Organization and the Centers for Disease Control and Prevention for accurate information. He notes that public health officials continue to closely monitor the situation, but at this stage the overall risk to the general public remains low. Interested in learning more? Simply click on Dr. Banach's icon to arrange a time to talk today.

It's Sports Science Week on The Academic Minute -- an entire week dedicated to UConn experts featured image

1 min

It's Sports Science Week on The Academic Minute -- an entire week dedicated to UConn experts

The Academic Minute is a two-and-a-half minute daily brief featuring researchers from colleges and universities around the world, keeping listeners abreast of what’s new and exciting in the academy. A different professor is featured each day, offering updates on groundbreaking research and how it helps us better understand the world around us. Hosted by Dr. Lynn Pasquerella, president of the American Association of Colleges and Universities, The Academic Minute airs on 70 stations around the United States and Canada, and twice daily on it's home station WAMC - Northeast Public Radio. This week, the entire program was focused on the science of sport with a new featured UConn expert each day. Monday Julie P. Burland, director of research at the Institute for Sports Medicine, examines how to predict in-season injuries for athletes. Tuesday Jennifer B. Fields, Assistant Professor in the Department of Nutritional Sciences, investigates why so many young athletes are flunking nutrition. Wednesday Dimitris Xygalatas, associate professor of anthropology, looks at sports fans for clues on how social rituals bind us together. Thursday Rebecca L. Stearns, associate professor-in-residence in the Department of Kinesiology, details potential strategies to prevent sudden deaths in sports. Friday Robert Huggins, assistant professor in the Department of Kinesiology, examines why there aren’t more athletic trainers on-hand at sporting events.

A Crisis of Caring featured image

3 min

A Crisis of Caring

Laura Mauldin's rule of thumb is that if you think you're caregiving, you probably are. The University of Connecticut professor and author has a new book that just been released In Sickness and in Health, where an urgent argument is made that America’s caregiving crisis is not a private family matter, but a structural and political failure.  Mauldin isn't just a scholar in the field. She also speaks from personal experience about the impact of caregiving -- as well as how society views and values it -- on both caregivers and those that they care for. It may not have been the birthday present then 32-year-old Laura Mauldin wanted to buy herself, but purchasing long-term care insurance was something she knew she needed. Mauldin, an associate professor in UConn’s Department of Social and Critical Inquiry, had been caring for her sick partner the five years prior, watching as cancer destroyed the promise of a long life. “It’s not about being morbid, rather it’s about recognizing the inevitability of a completely typical, expectable part of life,” Mauldin says of her advanced planning. “Why not just go ahead and in a neutral way have a plan? Then it’s there, you don’t have to worry, and you can feel more prepared.” A detailed account of her caregiving experience is the launching point for her new book, “In Sickness and in Health,” released this month by HarperCollins’ Ecco Press, in which she tells the story of a handful of couples from around the country who she came to know over years of spending time with them, oftentimes days and nights. “I grew to love these people and to care about them,” she says. “Their stories tell us something bigger about our culture, about our society, and about our choices around care policy and care systems. Theirs are the hidden stories that are going on behind millions of closed doors.” In her quest to bring discussions about caregiving to the light of day, Mauldin sat with UConn Today recently to talk about the different forms that caregiving can take, the result of absent social safety nets, and how ableism permeates the culture. February 2026 - UConn Today Drawing from her new book, Mauldin blends her personal experience with sociological research to show how love, marriage, and devotion are routinely forced to compensate for weak public policy, limited Medicaid support, and a culture shaped by ableism. Her work reframes caregiving as essential labor, deeply gendered, largely invisible, and profoundly political, and challenges the notion that “love is enough” in a system that offers far too little support. It’s an old adage: when people get married, they promise to stick together “in sickness and in health.” But that’s easier said than done when you’re caregiving for a spouse or long-term partner, when systemic failures often lead to burnout. In her new book, In Sickness and in Health: Love Stories from the Front Lines of America’s Caregiving Crisis, University of Connecticut professor Laura Mauldin explores the relationships between caregivers and their disabled and sick spouses, and the underlying lack of structural support in the US that makes unpaid care an inescapable feature of most such relationships. The topic is personal for her: Maudlin’s partner’s leukemia came out of remission as they were getting closer in 2006. “Falling in love with J had called upon me to increasingly fill a role that required meeting nearly every one of her needs,” Mauldin writes in her introduction. “This was more than just providing emotional support when the person you love is suffering.” J passed away in 2010. I spoke to Mauldin about crafting this book based on her lived experiences, how systems fail both disabled people and their caregivers, and what is at stake with Medicaid cuts exacerbating the damage to an already broken system. February 2026 - Mother Jones Dr. Laura Mauldin, an associate professor in the Department of Social and Critical Inquiry at the University of Connecticut, blends rigorous scholarship with lived experience to challenge prevailing assumptions about caregiving, disability, and public policy. Her work exposes how cultural norms and policy gaps intersect to offload care onto private homes, obscuring the true costs of care and the human toll of under-resourced support systems. She is available to speak with media - simply click on her icon now to arrange an interview today.

View all posts